Catalyst Wire Dossier Catalyst Wire Dossier

Pracytarabine

Pracytarabine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pracytarabine, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma [Phase 2, Phase 3]

See pricing